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BACKGROUND: Caring for an individual with Alzhei-
mer’s dementia (AD) is stressful, and studies show that
this stress has an impact on both the physical and
mental health of the caregiver. However, many ques-
tions remain about the characteristics of AD patients
and their caregivers that contribute to this stress and
how it impacts caregivers’ use of healthcare resources.
OBJECTIVE: To study the impact of stress on the
physical and mental health of the caregiver.
DESIGN: Patients underwent extensive testing to allow
description of their degree of cognitive impairment,
behavioral and psychological symptoms, medical
comorbidities, and functional abilities. Caregivers were
assessed for depressive symptoms and also for emer-
gency department (ED) use and hospitalizations in the
previous six months. Multivariate logistic regression
was used to evaluate impact of patients’ dementia
symptoms on caregivers’ acute care utilization.
PARTICIPANTS: One hundred and fifty-three AD
patients and their caregivers attending two large,
urban, university-affiliated primary care practices were
enrolled in a cross-sectional study to examine the facets
of dementia caregiving that impact caregiver acute
health care utilization.
RESULTS: Twenty-four percent of the caregivers had at
least one ED visit or hospitalization in the six months
prior to enrollment. After adjusting for caregiver age,
gender, and education, our logistic regression model
found that the caregivers’ acute care utilization was
associated with their depression as measured by the
PHQ-9 (OR 1.09, 95% CI 1.00–1.18), the patients’
behavioral and psychological symptoms as measured
by the NPI (OR 1.04, 95% CI 1.01–1.08), and the
patients’ functional status as measured by the ADCS-
ADL (OR 1.05, 95% CI 1.01–1.09).
CONCLUSION: To improve the health of AD caregivers, a
primary care system needs to reallocate resources to
manage the functional, behavioral, and psychological
symptoms related to the care-recipients suffering fromAD.
KEYWORDS: health care utilization; ED visit; hospitalization; dementia;
caregiver.
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INTRODUCTION
Approximately four million older adults in the United States
have Alzheimer’s dementia (AD), and three million of them are
living in the community.1 Family and friends are currently
providing 75% of the daily care needs of these patients, with
the remaining 25% being provided by purchased home care
services.2 Thus, dementing illnesses are complex in that they
impact not only the health and function of the patient but also
that of the caregiving family member or friend. With the aging
of the population, the number of cases of AD is anticipated to
increase to 18.5 million by 2050.3 If a similar proportion of AD
patients remains in the community as now, the burden of
caregiving on the family and friends by 2050 will increase
exponentially.
Caregiving is a stressful endeavor, and caring for a patient
with a dementing illness appears to be even more so. In a
national survey of more than 1,500 family caregivers, the
caregivers of demented patients described their duties as more
stressful compared to how caregivers of physically-impaired
but not demented older adults viewed theirs. The dementia
caregivers also reported spending significantly more hours per
week providing care, giving up their vacations or hobbies more
often, having less time for other family members, and having
more work-related problems.4
To evaluate the psychological effects of this stress of
caregiving, Schulz et al. reviewed the dementia literature to
evaluate the prevalence and magnitude of psychiatric com-
plaints in caregivers.5 Almost all studies reported increased
levels of depressive symptoms in caregivers, and this psychi-
atric morbidity was found to be correlated with not only patient
problem behaviors but also caregiver income, self-rated health,
perceived stress, and life satisfaction. In a more recent review,
Cuijpers systematically examined the dementia caregiving
literature for studies reporting actual diagnosis of a major
depressive disorder.6 He found that incidence and prevalence
of full-blown depression are also increased in caregivers of
dementia patients when compared to the non-caregiving
population. Thus, we know that the stress involved in caring
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for someone with dementia impacts the caregivers’ mental
health.
Studies have also examined whether dementia caregiving
has an effect on the caregivers’ physical health. Spousal
caregivers of patients with AD appear to have a greater risk
for developing serious illness,7 and being a caregiver under
mental or emotional strain was found to be an independent
risk factor for mortality in older spousal caregivers.8 Vitaliano
et al. conducted a meta-analysis of the dementia caregiving
literature.9 In the analysis, they combined the results of 23
studies that compared indicators of physical health in family
caregivers of demented patients to health indicators in non-
caregiver age- and sex-matched controls. Overall, caregivers
were found to have higher amounts of circulating stress
hormones and lower degrees of antibody responses compared
to the non-caregivers, but a definitive conclusion of whether
caregiving is directly hazardous to health could not be
determined.
Primary care physicians provide most of the medical care
both for patients with AD and for their caregivers. With the
aging of the population and the subsequent increase in
patients with AD, the effects of caregiving on the physical and
mental health of caregivers will continue to be important at
both the individual and societal level. A better understanding
of what makes caregiving of the demented more stressful is
needed, as is more study into how medical comorbidity of the
patient and the caregiver impacts their respective clinical
pictures. Where care of patients with AD is concerned, such
study may indicate that primary care providers need to expand
their definition of “patient” to include not only the demented
individual but the caregiver as well.
We describe a clinical profile of themedical comorbidity and the
cognitive, functional, behavioral and psychological symptoms
(BPSD) of a cohort of patients with AD. We then use this profile to
examine the impact of these symptoms on their caregivers’
emergency department and hospital utilizations. Based on our
clinical experience and previous research, our primary hypothe-
sis is that AD patients’ BPSD, not their cognition, will be
associated with their caregivers’ acute care utilization.
METHODS
The study was approved by the Indiana University Purdue
University-Indianapolis Institutional Review Board. All sub-
jects or their caregivers provided written informed consent for
participation.
Patients with AD were recruited from two large primary care
practices from January 2002 to August 2004. The first
practice included seven community-based health centers
affiliated with Wishard Health Services, a university-affiliated
urban health care system serving medically indigent patients
in Indianapolis. This practice serves approximately 5,000 older
adults. The second site included three primary care practices
at the Roudebush Veterans Affairs Medical Center in Indiana-
polis. This practice provides primary care to approximately
6,000 veterans age 65 and older.
Patients were recruited through two methods: (1) physician
referral following a written prompt that the patient may be
eligible due to a medical record diagnosis consistent with a
dementing illness; and (2) physician referral following a written
prompt from the research team that the patient screened
positive on cognitive testing. All patients aged 65 and older
who were receiving primary care from one of the two sites were
screened for dementia using a six-item screener instrument10
and an abbreviated version of the Community Screening
Instrument for Dementia (CSI-D).11 All referred patients
completed a formal diagnostic evaluation that included neu-
ropsychological testing, comprehensive physical examination,
a structured interview with the caregiver, brain imaging, and
reversible work-up for dementia. All results were reviewed by a
consensus diagnosis panel including a psychologist, neuro-
psychologist, geriatrician, and a geriatric psychiatrist. Sub-
jects were eligible if they met criteria for possible or probable
AD based on ICD-10 criteria. This diagnostic method is
described in more detail elsewhere.12 Exclusion criteria in-
cluded: residence in a nursing home, unable to understand
English, no access to a telephone, or no caregiver willing to
consent to participate in the study. The primary care physician
could then refer the patient to be enrolled in a randomized trial
to test the effectiveness of collaborative care management for
older adults with AD compared with augmented usual care. In
this study, caregivers were family members or friends who
identified themselves as individuals who assisted the subjects
with navigating daily life and who were willing to participate in
the study.
Patient Data. Following enrollment into the clinical trial and
as part of the baseline assessment, the caregivers completed
an assessment by telephone and thus were the primary
source of the patient’s data. The baseline interview included
standardized instruments developed by the Consortium of
Alzheimer Disease Center investigators13 and are considered
the current gold standard for health outcome measures for
patients with AD and their caregivers. These included the
Neuropsychiatric Inventory (NPI),14 the Alzheimer’s Disease
Cooperative Study-Activities of Daily Living Inventory (ADCS-
ADL),15 and Resource Use Inventory (RUI).13,16 The NPI has
been adopted by the Alzheimer’s Disease Cooperative Studies
(ADCS) Group to obtain information on the presence of
psychopathology in ten behavioral areas, including delusions,
apathy, hallucinations, disinhibition, agitation, depression,
aberrant motor behavior, anxiety, night-time behavior, and
euphoria. Possible scores range from 0–120, with high
numbers indicating more behavioral problems. The test has
excellent reliability and validity.14,17,18 The ADCS-ADL is
a 23-item inventory developed by the ADCS Group and is
administered to the patient’s caregiver by a trained interviewer.
The caregiver is asked to focus on the patient’s performance
over the past month. Notably, the caregiver reports on what the
patient actually did rather than an assessment of what the
patient might be able to do. Thus, the inventory focuses on
observed actions. The instrument assesses the traditional
basic activities of daily living as well as variations on
instrumental activities of daily living and a number of more
complex and explicit self-care tasks.15 Patients’ scores range
from 0–75, with higher scores indicating greater levels of
function. The RUI is a 15-item questionnaire developed by
the ADCS Group that is designed to measure the health care
utilization and costs incurred by subjects with AD. Three
categories of costs and use are assessed, including medical
services, discretionary health care costs, and caregiver
expenses. It inquires specifically about nursing home stays
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as well as home health visits, clinic visits, and hospitalizations.
Even though studies have proven that the RUI provides data
that are reliable and valid,16 in our previous studies we found
that older adults have difficulty recalling use over the prior
year.19 Thus, we completed the RUI for the previous six
months to improve recall.
All patients themselves completed the Telephone Interview
for Cognitive Status (TICS), a telephone version of the Mini-
Mental State Examination20 that has the same score range
from 0 to 30 with the higher number indicating less cognitive
impairment.
Using each patient’s list of prescribed medications, we
calculated the Chronic Disease Score (CDS) as a measure of
medical comorbidity.21 The CDS excludes medications used for
treatment of acute problems (such as antibiotics) or common
symptoms (such as nasal congestion). Individual medications
are assigned to pharmacy classes, which are then mapped to
the chronic diseases that class of medication would treat. Each
CDS class was assigned a weight by the original developers
based on expert judgment. These weights are used to calculate
the patient’s total CDS (range 0–24). The CDS has been
validated as an indicator of comorbidity, and its scores are
correlated with future resource utilization. Higher scores
indicate greater chronic disease burden and risk of healthcare
resource utilization.
Caregiver Data. In addition to providing information about the
patient’s status, the caregiver provided information about their
own demographics, their mood (PHQ-9), and their acute care
utilization (RUI). The Patient Health Questionnaire-9 (PHQ-9)22
assesses incidence and severity of each of the nine DSM-IV
criteria for depression, including anhedonia, appetite changes,
low energy, and difficulty concentrating. Scores can range from
0–27, with higher scores indicating worsening depression. They
also completed the RUI as a measure of their own acute
healthcare utilization.
ANALYSIS
We used two sample T-tests and Fisher’s exact test to compare
the demographic, neuropsychiatric inventory, and survey
measures of caregivers with an ED visit or hospital admission
to those without. We then used multivariate logistic regression
models to evaluate the impact of patients’ overall medical
comorbidity and dementia symptoms (functional, cognitive,
behavioral, and psychological symptoms) on the caregiver
acute utilization. Caregiver age, gender, education, and de-
pression (PHQ-9 score) were specified for model inclusion
regardless of p-value due to their clinical relevance and
importance.
RESULTS
Our study included 153 patients meeting ICD-10 criteria for
AD and their caregivers (Table 1). The patients’ mean age was
77.7 years (SD 5.8), 43% were female, and 49% were African
American. The average TICS score was 18.1 (SD 5.6) (indicat-
ing mild to moderate dementia), the mean ADCS-ADL scale
score was 50.0 (SD 15.8) (indicating fair patient functional
level), and the average NPI-12 score was 11.8 (SD 18.2)
(indicating moderate levels of BPSD). Caregivers had an
average age that was 16 years younger than the patients,
69% of them lived with the patient, and 89% were female.
Twenty-four percent of caregivers had at least one ED visit
or hospitalization. In assessing for caregiver characteristics
associated with this acute care utilization, bivariate analyses
found that these caregivers were caring for patients with more
BPSD (mean NPI 20.5 vs. 9, p=0.023) and less cognitive
impairment (mean TICS 19.1 vs. 16.6, p=0.057) and that
these caregivers suffered from more depressive symptoms
themselves (mean PHQ 6.1 vs. 3.4, p=0.044) (see Table 2).
Using multivariate logistic regression analyses to adjust for
the caregivers’ age, gender, education, and level of depression, we
found that caregiver acute care utilization was associated with
the patients’ behavioral and psychological symptoms (OR=1.04,
95% CI 1.01–1.08 for each one point increase on the NPI) and
their functional status (OR=1.05, 95% CI 1.01–1.09 for each one
point increase on the ADCS-ADL). However, we found no
association between caregivers’ acute care utilization and the
patients’ comorbidity or their cognitive function (see Table 3).
DISCUSSION
Our cross-sectional study conducted among AD patients and
their caregivers found that patients’ function and BPSD were
associated with utilization of acute care services by their
caregivers. We found no association between patients’ level of
cognitive impairment and caregivers’ acute care utilization.
Interestingly, this is somewhat different from what Shaw et al.
found in their study focusing on spousal caregivers of AD
patients. As in our study, when compared to controls, spousal
caregivers in Shaw et al.’s study showed a trend of higher risk
for having a serious illness that was associated with providing
Table 1. Characteristics of Patients and Caregivers
N=153
Patient variables % or Mean (SD)
% Female 43.1
% African American 49.0
Mean age 77.7 (5.8)
Mean years of education 9.2 (4.2)
% Married 48.4
Mean TICS 18.1 (5.6)
Mean ADCS-ADL 50.0 (15.8)
Mean NPI 11.8 (18.2)
Mean CDS 7.8 (3.9)
Caregiver variables
% Female 88.9
Mean age 60.9 (15.0)
Mean years of education 11.9 (2.7)
% Live with patient 69.3
% Patient’s spouse 44.4
Mean PHQ-9 4.1 (5.3)
% ED visit prior 6 months 20.9
% Inpatient admission prior 6 months 10.5
% ED visit or inpatient admission prior 6 months 24.2
* TICS = Telephone Interview for Cognitive Status, ADCS-ADL = Alzhei-
mer’s Disease Cooperative Study-Activities of Daily Living, NPI = Neuro-
psychiatric Inventory, CDS = Chronic Disease Score, ED = emergency
department, PHQ-9 = Patient Health Questionnaire
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more ADL and functional assistance to the patient; however,
they found no association with the patients’ BPSD.7 As Shaw’s
study focused exclusively on spousal caregivers and ours,
however, included any informal caregiver, direct comparisons
cannot be made.
This association between patients’ function and BPSD and
caregiver use of health care services is an indicator of the
difficulty of managing and caring for patients suffering from
AD. In fact, BPSD, but not cognitive impairment, have been
shown to be a prominent factor in the caregiver’s decision to
seek long-term residential placement for the patient.23 Thus, it
is not as much the patient’s loss of cognitive function that
stresses caregivers, perhaps because the caregiver expects and
is prepared for this as part of the dementing illness. Rather,
the agitation, aggression, and other symptoms contribute most
heavily to caregiver stress and burden.
As our population ages and the numbers of AD cases
increases, by necessity the number of caregivers, both formal
and informal, will also increase. Unless our medical system
can begin better to address and treat the BPSD of the
demented patient, caregiver stress will continue unabated. In
addition, our study found that the caregivers with more
depressive symptoms were more likely to utilize acute health-
care resources. This is in line with the results of other studies
of depression and its impact on use of health resources.24
Thus, to truly impact the care of the AD patient and caregiver,
we need to include assessment and treatment of psychological
symptoms of the caregiver, too.
Our study demonstrated that AD caregiving produces
significant stress that impacts both the medical and psycho-
logical wellbeing of caregivers. Thus, our primary health care
system needs to change its approach to providing medical care
to AD patients. Rather than caring only for the demented
patient, primary care providers will need to expand their
definition of “patient” to include the caregiver as well.
Collaborative care programs within the primary care and
home settings offer the best possibility for managing patients’
symptoms while supporting the caregivers’ efforts to care for
them at home and reducing the need for utilization of acute
care services.25–27 Recent trials of such collaborative interven-
tions included in-home education and psychosocial support
for the caregiver on issues such as caregiver depression and
burden and patients’ BPSD.25–27 The collaborative interven-
tions studied were successful in reducing caregiver stress and
improving quality of life.25–27 In addition, patient’s behavioral
and psychological symptoms were reduced as a result of the
collaborative interventions.25 However, further research is
needed to fully describe such a program and to evaluate its
feasibility in clinical practice.
Our study has important internal and external validity
limitations. First, the external validity of the findings is limited
because our data are from patient–caregiver dyads that were
willing to pursue both an evaluation of cognitive impairment,
enroll in a clinical trial, and receive care in two specific health
care systems. Our study group had a high percentage of
African Americans, so the results may not be generalizable to
all populations. On the other hand, minorities tend to be
underrepresented in many studies of AD, so our report offers a
unique glimpse into how AD impacts a minority population.
Second, the cross-sectional design of our study limits its
internal validity and its capability of determining a cause-
and-effect relationship. Third, our information on ED/hospital
utilization over the six months prior to the study was obtained
from caregiver interview using the RUI. Thus, it is conceivable
that some acute care visits were not reported and that our
prevalence rate is conservative. Fourth, we did not collect
information on the specific reasons for the caregivers’ ED visits
or hospitalizations, so we cannot comment on whether these
were ambulatory care sensitive conditions such that caregiving
duties might have interfered with non-emergent treatment or if
an episode of patient’s BPSD led directly to a caregiver ED visit.
Our study reveals the importance and impact of functional
and BPSD symptoms in Alzheimer dementia on caregivers’ use of
acute healthcare services. Improved management of such symp-
toms in the primary care system may lead to a significant
decrease in the burden of AD, not just for the patient and
caregiver but also for the healthcare system at large. Further
research efforts are necessary to better describe effective,
practical methods to provide this management in primary care.
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